The role of intracochlear drug delivery devices in the management of inner ear disease

Bibliography

• Holley MC. Keynote review: the auditory system, hearing loss and potential targets for drug development. Drug Discov Today 2005;10:1269–82
   PubMed Web of Science ®Google Scholar
• Quick Statistics. National Institutes of Health (NIH). 2010. Available from: http://www.nidcd.nih.gov/health/statistics/Pages/quick.aspx
   Google Scholar
• Hawkins K, Bottone FGJr, Ozminkowski RJ, et al. The prevalence of hearing impairment and its burden on the quality of life among adults with Medicare Supplement Insurance. Qual Life Res 2012;21:1135-47
   PubMed Web of Science ®Google Scholar
• Jarvis L. Sound science. Chem Eng News 2014;92:12-17
   Web of Science ®Google Scholar
• Swan EE, Mescher MJ, Sewell WF, et al. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008;60:1583-99
   PubMed Web of Science ®Google Scholar
• Juhn SK, Rybak LP, Fowlks WL. Transport characteristics of the blood–perilymph barrier. Am J Otolaryngol 1982;3:392-6
   PubMed Web of Science ®Google Scholar
• Alexander TH, Weisman MH, Derebery JM, et al. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol 2009;30:443-8
   PubMed Web of Science ®Google Scholar
• Perez N, Martin E, Garcia-Tapia R. Intratympanic gentamicin for intractable Meniere’s disease. Laryngoscope 2003;113:456-64
   PubMed Web of Science ®Google Scholar
• Goycoolea MV. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol 2001;121:437-47
   PubMed Web of Science ®Google Scholar
• Igarashi M, Ohashi K, Ishii M. Morphometric comparison of endolymphatic and perilymphatic spaces in human temporal bones. Acta Otolaryngol 1986;101:161-4
   PubMed Web of Science ®Google Scholar
• Quesnel AM, Seton M, Merchant SN, et al. Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. Otol Neurotol 2012;33:1308-14
   PubMed Web of Science ®Google Scholar
• Silverstein H. Streptomycin treatment for Meniere’s disease. Ann Otol Rhinol Laryngol Suppl 1984;112:44-8
   PubMedGoogle Scholar
• Pararas EE, Borkholder DA, Borenstein JT. Microsystems technologies for drug delivery to the inner ear. Adv Drug Deliv Rev 2012;64:1650-60
   PubMed Web of Science ®Google Scholar
• Brown JN, Miller JM, Altschuler RA, et al. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res 1993;70:167-72
   PubMed Web of Science ®Google Scholar
• Borkholder DA. State-of-the-art mechanisms of intracochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg 2008;16:472-7
   PubMed Web of Science ®Google Scholar
• Swan EE, Peppi M, Chen Z, et al. Proteomics analysis of perilymph and cerebrospinal fluid in mouse. Laryngoscope 2009;119:953-8
   PubMed Web of Science ®Google Scholar
• Borenstein JT. Intracochlear drug delivery systems. Expert Opin Drug Deliv 2011;8:1161-74
   PubMed Web of Science ®Google Scholar
• Nakashima T, Naganawa S, Sone M, et al. Disorders of cochlear blood flow. Brain Res Brain Res Rev 2003;43:17-28
   PubMed Web of Science ®Google Scholar
• Miller JM, Ren TY, Nuttall AL. Studies of inner ear blood flow in animals and human beings. Otolaryngol Head Neck Surg 1995;112:101-13
   PubMed Web of Science ®Google Scholar
• Suzuki M, Yamasoba T, Kaga K. Development of the blood-labyrinth barrier in the rat. Hear Res 1998;116:107-12
   PubMed Web of Science ®Google Scholar
• Bobbin RP, Konishi T. Acetylcholine mimics crossed olivocochlear bundle stimulation. Nat New Biol 1971;231:222-3
   PubMedGoogle Scholar
• Kang BJ, Kim AH. Comparison of cochlear implant performance after round window electrode insertion compared with traditional cochleostomy. Otolaryngol Head Neck Surg 2013;148:822-6
   PubMed Web of Science ®Google Scholar
• Cohen NL, Hoffman RA. Complications of cochlear implant surgery in adults and children. Ann Otol Rhinol Laryngol 1991;100:708-11
   PubMed Web of Science ®Google Scholar
• Sudden sensorineural hearing loss immediately following stapedectomy. In: De Souza C, Glasscock M, editors. Otosclerosis and stapedectomy: diagnosis, management & complications. Thieme Medical Publishers; NY, USA: 2004. p. 137-40
   Google Scholar
• Hongjian L, Guangke W, Song M, et al. The prediction of CSF gusher in cochlear implants with inner ear abnormality. Acta Otolaryngol 2012;132:1271-4
   PubMed Web of Science ®Google Scholar
• Choi CH, Oghalai JS. Predicting the effect of post-implant cochlear fibrosis on residual hearing. Hear Res 2005;205:193-200
   PubMed Web of Science ®Google Scholar
• Chen Z, Kujawa SG, McKenna MJ, et al. Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Control Release 2005;110:1-19
   PubMed Web of Science ®Google Scholar
• Ozkul Y, Songu M, Basoglu MS, et al. Evaluation of the protective effect of alpha-lipoic acid on cisplatin ototoxicity using distortion-product otoacoustic emission measurements: an experimental animal study. J Craniofac Surg 2014;25:1515-18
   PubMed Web of Science ®Google Scholar
• Zhan W, Cruickshanks KJ, Klein BE, et al. Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol 2010;171:260-6
   PubMed Web of Science ®Google Scholar
• Rajguru R. Military aircrew and noise-induced hearing loss: prevention and management. Aviat Space Environ Med 2013;84:1268-76
   PubMed Web of Science ®Google Scholar
• Liberman MC, Dodds LW. Single-neuron labeling and chronic cochlear pathology. III. Stereocilia damage and alterations of threshold tuning curves. Hear Res 1984;16:55-74
   PubMed Web of Science ®Google Scholar
• Abi-Hachem RN, Zine A, Van De Water TR. The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies. Recent Pat CNS Drug Discov 2010;5:147-63
   PubMedGoogle Scholar
• Wang J, Van De Water TR, Bonny C, et al. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J Neurosci 2003;23:8596-607
   PubMed Web of Science ®Google Scholar
• Kil J, Pierce C, Tran H, et al. Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase. Hear Res 2007;226:44-51
   PubMed Web of Science ®Google Scholar
• Kusunoki T, Cureoglu S, Schachern PA, et al. Age-related histopathologic changes in the human cochlea: a temporal bone study. Otolaryngol Head Neck Surg 2004;131:897-903
   PubMed Web of Science ®Google Scholar
• Kujawa SG, Liberman MC. Adding insult to injury: cochlear nerve degeneration after "temporary" noise-induced hearing loss. J Neurosci 2009;29:14077-85
   PubMed Web of Science ®Google Scholar
• Malhotra H. Cisplatin ototoxicity. Indian J Cancer 2009;46:262-3
   PubMedGoogle Scholar
• Brock PR, Knight KR, Freyer DR, et al. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol 2012;30:2408-17
   PubMed Web of Science ®Google Scholar
• Huth ME, Ricci AJ, Cheng AG. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int J Otolaryngol 2011;2011:937861
   PubMedGoogle Scholar
• Gonzalez LSIII, Spencer JP. Aminoglycosides: a practical review. Am Fam Physician 1998;58:1811-20
   PubMed Web of Science ®Google Scholar
• Md Daud M, MohamadI H, Haron A, et al. Otoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions. B-ENT 2014;10:53-8
   PubMed Web of Science ®Google Scholar
• Ylikoski J, Savolainen S. Cochlear nerve fiber populations in 25 patients with profound deafness due to Meniere’s disease or sudden deafness. Arch Otorhinolaryngol 1982;234:157-61
   PubMedGoogle Scholar
• Fisher LM, Derebery MJ, Friedman RA. Oral steroid treatment for hearing improvement in Meniere’s disease and endolymphatic hydrops. Otol Neurotol 2012;33:1685-91
   PubMed Web of Science ®Google Scholar
• Buniel MC, Geelan-Hansen K, Weber PC, et al. Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy 2009;1:425-34
   PubMed Web of Science ®Google Scholar
• Wei BP, Stathopoulos D, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2013;7:CD003998
   PubMedGoogle Scholar
• Nakagawa T, Yamane H, Shibata S, et al. Gentamicin ototoxicity induced apoptosis of the vestibular hair cells of guinea pigs. Eur Arch Otorhinolaryngol 1997;254:9-14
   PubMed Web of Science ®Google Scholar
• Kaplan DM, Nedzelski JM, Al-Abidi A, et al. Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere’s disease. J Otolaryngol 2002;31:106-11
   PubMedGoogle Scholar
• Suryanarayanan R, Srinivasan VR, O’Sullivan G. Transtympanic gentamicin treatment using Silverstein MicroWick in Meniere’s disease patients: long term outcome. J Laryngol Otol 2009;123:45-9
   PubMed Web of Science ®Google Scholar
• Hoffer ME, Kopke RD, Weisskopf P, et al. Microdose gentamicin administration via the round window microcatheter: results in patients with Meniere’s disease. Ann N Y Acad Sci 2001;942:46-51
   PubMed Web of Science ®Google Scholar
• Silverstein H, Arruda J, Rosenberg SI, et al. Direct round window membrane application of gentamicin in the treatment of Meniere’s disease. Otolaryngol Head Neck Surg 1999;120:649-55
   PubMed Web of Science ®Google Scholar
• Lacour M. Betahistine treatment in managing vertigo and improving vestibular compensation: clarification. J Vestib Res 2013;23:139-51
   PubMed Web of Science ®Google Scholar
• Langguth B, Kreuzer PM, Kleinjung T, et al. Tinnitus: causes and clinical management. Lancet Neurol 2013;12:920-30
   PubMed Web of Science ®Google Scholar
• Kaltenbach JA. Tinnitus: models and mechanisms. Hear Res 2011;276:52-60
   PubMed Web of Science ®Google Scholar
• Bennett MH, Kertesz T, Yeung P. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2007;CD004739
   PubMedGoogle Scholar
• Raghunandhan S, Agarwal AK, Natarajan K, et al. Effect of intravenous administration of steroids in the management of sudden sensori-neural hearing loss: our experience. Indian J Otolaryngol Head Neck Surg 2013;65:229-33
   Web of Science ®Google Scholar
• Silverstein H, Thompson J, Rosenberg SI, et al. Silverstein MicroWick. Otolaryngol Clin North Am 2004;37:1019-34
   PubMed Web of Science ®Google Scholar
• Hill SLIII, Digges EN, Silverstein H. Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Meniere’s disease. Ear Nose Throat J 2006;85:494, 496, 498
   PubMedGoogle Scholar
• Chou YF, Chen PR, Kuo IJ, et al. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss. Laryngoscope 2013;123:2264-9
   PubMed Web of Science ®Google Scholar
• Barriat S, van Wijck F, Staecker H, et al. Intratympanic steroid therapy using the Silverstein Microwick for refractory sudden sensorineural hearing loss increases speech intelligibility. Audiol Neurootol 2012;17:105-11
   PubMed Web of Science ®Google Scholar
• Van Wijck F, Staecker H, Lefebvre PP. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol 2007;127:1012-17
   PubMed Web of Science ®Google Scholar
• Plontke SK, Zimmermann R, Zenner HP, et al. Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects. Otol Neurotol 2006;27:912-17
   PubMed Web of Science ®Google Scholar
• Plontke SK, Salt AN. Simulation of application strategies for local drug delivery to the inner ear. ORL J Otorhinolaryngol Relat Spec 2006;68:386-92
   PubMed Web of Science ®Google Scholar
• Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 2002;122:698-702
   PubMed Web of Science ®Google Scholar
• Piu F, Wang X, Fernandez R, et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurotol 2011;32:171-9
   PubMed Web of Science ®Google Scholar
• Pasic TR, Rubel EW. Rapid changes in cochlear nucleus cell size following blockade of auditory nerve electrical activity in gerbils. J Comp Neurol 1989;283:474-80
   PubMed Web of Science ®Google Scholar
• Havenith S, Versnel H, Agterberg MJ, et al. Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier. Hear Res 2011;272:168-77
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grossiord JL, Agnely F, et al. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006;23:2709-28
   PubMed Web of Science ®Google Scholar
• Lambert PR, Nguyen S, Maxwell KS, et al. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Meniere’s disease. Otol Neurotol 2012;33:1257-65
   PubMed Web of Science ®Google Scholar
• Engleder E, Honeder C, Klobasa J, et al. Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear. Int J Pharm 2014;471:297-302
   PubMed Web of Science ®Google Scholar
• Lajud SA, Han Z, Chi FL, et al. A regulated delivery system for inner ear drug application. J Control Release 2013;166:268-76
   PubMed Web of Science ®Google Scholar
• Kingma GG, Miller JM, Myers MW. Chronic drug infusion into the scala tympani of the guinea pig cochlea. J Neurosci Methods 1992;45:127-34
   PubMed Web of Science ®Google Scholar
• Wang J, Lloyd Faulconbridge RV, Fetoni A, et al. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology 2003;45:380-93
   PubMed Web of Science ®Google Scholar
• Nair TS, Prieskorn DM, Miller JM, et al. KHRI-3 monoclonal antibody-induced damage to the inner ear: antibody staining of nascent scars. Hear Res 1999;129:50-60
   PubMed Web of Science ®Google Scholar
• Agterberg MJ, Versnel H, de Groot JC, et al. Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Hear Res 2008;244:25-34
   PubMed Web of Science ®Google Scholar
• Toyota H, Shimogori H, Sugahara K, et al. A novel treatment for vestibular disorder with FGLM-NH2 plus SSSR. Neurosci Lett 2012;526:128-32
   PubMed Web of Science ®Google Scholar
• Lalwani AK, Walsh BJ, Reilly PG, et al. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Ther 1996;3:588-92
   PubMed Web of Science ®Google Scholar
• Zou J, Sood R, Zhang Y, et al. Pathway and morphological transformation of liposome nanocarriers after release from a novel sustained inner-ear delivery system. Nanomedicine (Lond) 2014. [ Epub ahead of print]
   Web of Science ®Google Scholar
• Kujawa SG, Fallon M, Bobbin RP. ATP antagonists cibacron blue, basilen blue and suramin alter sound-evoked responses of the cochlea and auditory nerve. Hear Res 1994;78:181-8
   PubMed Web of Science ®Google Scholar
• Prieskorn DM, Miller JM. Technical report: chronic and acute intracochlear infusion in rodents. Hear Res 2000;140:212-15
   PubMed Web of Science ®Google Scholar
• Praetorius M, Brunner C, Lehnert B, et al. Transsynaptic delivery of nanoparticles to the central auditory nervous system. Acta Otolaryngol 2007;127:486-90
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen G, Wen L, et al. Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in vitro and in vivo evaluation. Eur J Pharm Sci 2013;48:595-603
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang W, Lobler M, et al. Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int J Pharm 2011;404:211-19
   PubMed Web of Science ®Google Scholar
• Buckiova D, Ranjan S, Newman TA, et al. Minimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membrane. Nanomedicine (Lond) 2012;7:1339-54
   PubMed Web of Science ®Google Scholar
• Scheper V, Wolf M, Scholl M, et al. Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomedicine (Lond) 2009;4:623-35
   PubMed Web of Science ®Google Scholar
• Kopke RD, Wassel RA, Mondalek F, et al. Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant. Audiol Neurootol 2006;11:123-33
   PubMed Web of Science ®Google Scholar
• Pritz CO, Dudas J, Rask-Andersen H, et al. Nanomedicine strategies for drug delivery to the ear. Nanomedicine (Lond) 2013;8:1155-72
   PubMed Web of Science ®Google Scholar
• Youm I, Youan BB. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines. Hear Res 2013;304:7-19
   PubMed Web of Science ®Google Scholar
• Zou J, Zhang Y, Zhang W, et al. Internalization of liposome nanoparticles functionalized with TrkB ligand in rat cochlear cell populations. Eur J Nanomed 2008;3:8-16
   Google Scholar
• Chen Z, Mikulec AA, McKenna MJ, et al. A method for intracochlear drug delivery in the mouse. J Neurosci Methods 2006;150:67-73
   PubMed Web of Science ®Google Scholar
• Wei Y, Fu Y, Liu S, et al. Effect of lentiviruses carrying enhanced green fluorescent protein injected into the scala media through a cochleostomy in rats. Am J Otolaryngol 2013;34:301-7
   PubMed Web of Science ®Google Scholar
• Borkholder DA, Zhu X, Hyatt BT, et al. Murine intracochlear drug delivery: reducing concentration gradients within the cochlea. Hear Res 2010;268:2-11
   PubMed Web of Science ®Google Scholar
• Addams-Williams J, Munaweera L, Coleman B, et al. Cochlear implant electrode insertion: in defence of cochleostomy and factors against the round window membrane approach. Cochlear Implants Int 2011;12(Suppl 2):S36-9
   Google Scholar
• Coordes A, Ernst A, Brademann G, et al. Round window membrane insertion with perimodiolar cochlear implant electrodes. Otol Neurotol 2013;34:1027-32
   PubMed Web of Science ®Google Scholar
• Adunka O, Kiefer J. Impact of electrode insertion depth on intracochlear trauma. Otolaryngol Head Neck Surg 2006;135:374-82
   PubMed Web of Science ®Google Scholar
• Eastwood H, Chang A, Kel G, et al. Round window delivery of dexamethasone ameliorates local and remote hearing loss produced by cochlear implantation into the second turn of the guinea pig cochlea. Hear Res 2010;265:25-9
   PubMed Web of Science ®Google Scholar
• Farahmandghavi F, Imani M, Mirzadeh H, et al. Curing behavior of silicone elastomer in the presence of two corticosteroid drugs. J Biomed Mater Res B Appl Biomater 2012;100:1636-44
   PubMedGoogle Scholar
• Astolfi L, Guaran V, Marchetti N, et al. Cochlear implants and drug delivery: in vitro evaluation of dexamethasone release. J Biomed Mater Res B Appl Biomater 2014;102:267-73
   PubMed Web of Science ®Google Scholar
• Farahmand Ghavi F, Mirzadeh H, Imani M, et al. Corticosteroid-releasing cochlear implant: a novel hybrid of biomaterial and drug delivery system. J Biomed Mater Res B Appl Biomater 2010;94:388-98
   PubMedGoogle Scholar
• Niedermeier K, Braun S, Fauser C, et al. A safety evaluation of dexamethasone-releasing cochlear implants: comparative study on the risk of otogenic meningitis after implantation. Acta Otolaryngol 2012;132:1252-60
   PubMed Web of Science ®Google Scholar
• Radeloff A, Unkelbach MH, Mack MG, et al. A coated electrode carrier for cochlear implantation reduces insertion forces. Laryngoscope 2009;119:959-63
   PubMed Web of Science ®Google Scholar
• Warnecke A, Wissel K, Hoffmann A, et al. The biological effects of cell-delivered brain-derived neurotrophic factor on cultured spiral ganglion cells. Neuroreport 2007;18:1683-6
   PubMed Web of Science ®Google Scholar
• Richardson RT, Wise AK, Thompson BC, et al. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 2009;30:2614-24
   PubMed Web of Science ®Google Scholar
• Evans AJ, Thompson BC, Wallace GG, et al. Promoting neurite outgrowth from spiral ganglion neuron explants using polypyrrole/BDNF-coated electrodes. J Biomed Mater Res A 2009;91:241-50
   PubMed Web of Science ®Google Scholar
• Paasche G, Bogel L, Leinung M, et al. Substance distribution in a cochlea model using different pump rates for cochlear implant drug delivery electrode prototypes. Hear Res 2006;212:74-82
   PubMed Web of Science ®Google Scholar
• Sewell WF, Borenstein JT, Chen Z, et al. Development of a microfluidics-based intracochlear drug delivery device. Audiol Neurootol 2009;14:411-22
   PubMed Web of Science ®Google Scholar
• Pararas EE, Chen Z, Fiering J, et al. Kinetics of reciprocating drug delivery to the inner ear. J Control Release 2011;152:270-7
   PubMed Web of Science ®Google Scholar
• Kim ES, Gustenhoven E, Mescher MJ, et al. A microfluidic reciprocating intracochlear drug delivery system with reservoir and active dose control. Lab Chip 2014;14:710-21
   PubMed Web of Science ®Google Scholar
• Handzel O, Wang H, Fiering J, et al. Mastoid cavity dimensions and shape: method of measurement and virtual fitting of implantable devices. Audiol Neurootol 2009;14:308-14
   PubMed Web of Science ®Google Scholar
• Plontke S, Siedow N, Hahn H, et al. [1D-and 3D- computer simulation for experimental planning and interpretation of pharmacokinetic studies in the inner ear after local drug delivery]. ALTEX 2004;21(Suppl 3):77-85
   PubMedGoogle Scholar
• Plontke SK, Siedow N, Wegener R, et al. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiol Neurootol 2007;12:37-48
   PubMed Web of Science ®Google Scholar
• Salt AN, Hartsock J, Plontke S, et al. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation. Audiol Neurootol 2011;16:323-35
   PubMed Web of Science ®Google Scholar
• Borenstein JT, Swan EE, Sewell WF. Computational reaction-diffusion model for microfluidic drug delivery. Association for Research in Otolaryngology; Baltimore, MD, USA; 2011
   Google Scholar